TFF Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of TFF Pharmaceuticals generated cash of -$16,038,195, which is more than the previous year. Cash used in financing activities reached the amount of $5,013,412 last year. Net change in cash is therefore -$11,134,202.
Cash Flow
| 2017 | -187.74K | 0 | 187.74K |
|---|---|---|---|
| 2019 | -11.21M | 0 | 29.04M |
| 2020 | -16.61M | -1.10M | 24.99M |
| 2021 | -29.55M | -868.50K | 28.88M |
| 2022 | -27.34M | -1.55M | 11.75M |
| 2023 | -16.03M | -94.75K | 5.01M |
TFFP Cash Flow Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 16.61M | 33.79M | 35.30M | 28.09M | 10.26M | 0 |
Operating activities | ||||||
Net income | -21.24M | -31.77M | -31.03M | -18.56M | -11.87M | -178.60K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 502.48K | 388.22K | 111.45K | 0 | 0 | 0 |
Stock-based compensation expense | 2.92M | 4.25M | 3.54M | 2.18M | 590.04K | 0 |
| Deferred income tax benefit | 2.92M | 4.25M | 3.54M | 2.18M | 590.04K | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 0 | 567.13K | -2.62M | 0 | 0 | 0 |
Inventories | 0 | -567.13K | 2.62M | 0 | 0 | 0 |
Accounts payable | 38.38K | -577.10K | 209.19K | 862.67K | 12.44K | -9.14K |
Cash generated by operating activities | -16.03M | -27.34M | -29.55M | -16.61M | -11.21M | -187.74K |
Investing activities | ||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -94.75K | -1.55M | -868.50K | -1.10M | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -94.75K | -1.55M | -868.50K | -1.10M | 0 | 0 |
Financing activities | ||||||
Common Stock Issued | 5.12M | 11.64M | 28.88M | 24.28M | 21.85M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | -875.35K | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 5.01M | 11.75M | 28.88M | 24.99M | 29.04M | 187.74K |
Net Change In Cash | -11.13M | -17.18M | -1.50M | 7.20M | 17.83M | 0 |
Cash at end of period | 5.47M | 16.61M | 33.79M | 35.30M | 28.09M | 0 |
| Data source | Data source | Data source | Data source | Data source |